Stay updated on Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots. The study details and eligibility criteria appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:10:59.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T10:09:02.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:13:00.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The Back to Top element was removed; no other substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-13T17:15:51.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T14:55:59.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, particularly in South Korea and China, while removing several previous location references and medical topics. Additionally, new related topics and a revision number have been added.
    Difference
    8%
    Check dated 2025-08-30T11:34:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Paclitaxel in Asian Gastric Cancer Clinical Trial page.